Brought to you by 
British Biotech, Evotec discover PDF inhibitors
27 Apr 2021
Executive Summary
British Biotech PLC's (matrix metalloproteinase inhibitors, MMPIs) and the German biotech Evotec OAI (drug discovery tools) have teamed up to discover anti-infective drugs, using Evotec's medicinal and computational chemistry technologies.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
- ADMET
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Alliance
- Intra-Biotech Deal
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
British Biotech, Evotec discover PDF inhibitors
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice